Announcements Trials
Browse Landscape

Status

Recruiting 3Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 28Observational 4

Sponsor

Cancer Type

Breast 2Lymphoid 1

Conditions

Breast Neoplasms 693Neoplasms 610Prostatic Neoplasms 320Lung Neoplasms 309Colorectal Neoplasms 281Carcinoma, Non-Small-Cell Lung 253Pancreatic Neoplasms 178Carcinoma, Hepatocellular 169Stomach Neoplasms 143Multiple Myeloma 127Ovarian Neoplasms 121Melanoma 116Colonic Neoplasms 114Brain Neoplasms 108Hematologic Neoplasms 106Head and Neck Neoplasms 103Urinary Bladder Neoplasms 102Leukemia, Myeloid, Acute 100Esophageal Neoplasms 100Disease 97Liver Neoplasms 92Uterine Cervical Neoplasms 90Neoplasm Metastasis 89Lymphoma 86Rectal Neoplasms 85Precursor Cell Lymphoblastic Leukemia-Lymphoma 82Endometrial Neoplasms 78Carcinoma, Renal Cell 74Leukemia 65Sarcoma 63

Interventions

Patient Reported Outcome Measures 1Observation 1Independent Medical Evaluation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Observational × Pathologic Complete Response × 1 year × Clear all
NCT05926024 2026-03-11

Long-Term Follow-Up in Women With Early Breast Cancer Three Years of More Post Primary Treatment

UNC Lineberger Comprehensive Cancer Center

Active not recruiting
253 enrolled
Breast

Pathologic Complete Response, Breast Neoplasms

NCT07353840 2026-01-20

T-START-CR

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Recruiting
160 enrolled
Lymphoid

Pathologic Complete Response, Lymphoma, T-Cell, Peripheral

NCT06364371 2025-12-18

Dynamic Multi-omics Integration Model to Predict Neoadjuvant Therapy Response in Locally Advanced Rectal Cancer

Sixth Affiliated Hospital, Sun Yat-sen University

Recruiting
106 enrolled

Pathologic Complete Response

NCT07166185 2025-09-10

NEOTRAPSCAL

Blida 1 University

Recruiting
70 enrolled
Breast

Pathologic Complete Response, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡